| Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
OR | 95% CI for OR | p | OR | 95% CI for OR | p | |
Age at diagnosis | 1.243 | 0.869–1.779 | 0.2343 |  |  |  |
  ≤ 35 | 1 | - |  |  |  | |
 36–40 | 1.000 | 0.429–2.331 | 1.0000 |  |  | |
 41–45 | 1.417 | 0.658–3.050 | 0.3727 |  |  | |
>/= 1 children before breast cancer diagnosis | 1.291 | 0.715–2.332 | 0.3695 |  |  | |
1st degree relative with breast cancer | 0.926 | 0.316–2.715 | 0.8885 |  |  | |
ER positive | 0.517 | 0.298–0.895 | 0.0186 | 0.552 | 0.311–0.980 | 0.0423 |
PR positive | 0.712 | 0.419–1.213 | 0.2115 |  |  |  |
HER2 over-expression | 1.187 | 0.610–2.309 | 0.6134 |  |  | |
Received adjuvant radiotherapy | 0.866 | 0.508–1.477 | 0.5984 |  |  | |
Received adjuvant taxane-containing chemotherapy | 0.887 | 0.501–1.568 | 0.6790 |  |  | |
Duration of adjuvant chemotherapy >64 days | 0.828 | 0.483–1.420 | 0.4928 |  |  | |
Received corticosteroid premedication during chemotherapy | 1.046 | 0.410–2.667 | 0.9251 |  |  | |
Received adjuvant tamoxifen therapy | 0.557 | 0.313–0.990 | 0.0462 |  |  | |
Received adjuvant trastuzumab | 1.352 | 0.316–5.789 | 0.6846 |  |  | |
Use of traditional Chinese medicine since diagnosis | 0.947 | 0.542–1.655 | 0.8486 |  |  | |
Education | 0.789 | 0.507–1.228 | 0.2936 |  |  | |
 Primary school | 1 | - | - |  |  | |
 Secondary school | 0.907 | 0.461–1.787 | 0.7784 |  |  | |
 Tertiary school + Higher qualification | 0.609 | 0.246–1.509 | 0.2840 |  |  | |
Employment- Working | 0.815 | 0.485–1.369 | 0.4397 |  |  | |
Family income </= HK$ 25,000 | 0.753 | 0.441–1.287 | 0.3000 |  |  | |
Ever Smoker | 0.271 | 0.033–2.198 | 0.2214 |  |  | |
Ever excessive alcohol intake (>2Â units/day) | - | - | 0.9877 | Â | Â | |
Chemotherapy-related amenorrhea | 0.778 | 0.329–1.838 | 0.5665 |  |  | |
Post/peri- menopausal at study entry | 0.930 | 0.559–1.548 | 0.7808 |  |  | |
Weight gain >2% at study entry | 1.095 | 0.644–1.864 | 0.7371 |  |  | |
Total Cholesterol >/= 5.2 mmol/L | 1.475 | 0.865–2.516 | 0.1534 |  |  | |
LDL Cholesterol >/= 2.6 mmol/L | 1.762 | 1.027–3.021 | 0.0396 |  |  | |
HDL Cholesterol </= 1.0 mmol/L | 1.842 | 0.700–4.850 | 0.2160 |  |  | |
Triglyceride >/=1.7 mmol/L | 1.568 | 0.867–2.836 | 0.1364 |  |  | |
Overweight/obese at study entry | 2.751 | 1.608–4.707 | 0.0002 | 2.723 | 1.568–4.728 | 0.0004 |
Age at study entry | 1.173 | 0.852–1.614 | 0.3273 |  |  |  |
  ≤ 40 | 1 | - |  |  |  | |
 41–45 | 1.929 | 0.738–5.037 | 0.1799 |  |  | |
 46–50 | 1.774 | 0.720–4.371 | 0.2126 |  |  | |
  > 50 | 2.057 | 0.623–6.794 | 0.2367 |  |  |